Running Oak Capital’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.2M Sell
48,335
-9,985
-17% -$2.14M 1.74% 34
2026
Q1
$12.9M Sell
58,320
-1,718
-3% -$420K 1.74% 39
2025
Q4
$15.2M Sell
60,038
-6,781
-10% -$1.7M 1.91% 19
2025
Q3
$16.5M Sell
66,819
-1,296
-2% -$310K 1.85% 23
2025
Q2
$16.4M Buy
68,115
+1,656
+2% +$386K 1.82% 34
2025
Q1
$15.1M Buy
66,459
+7,183
+12% +$1.58M 1.82% 36
2024
Q4
$12.2M Buy
59,276
+7,493
+14% +$1.64M 1.59% 48
2024
Q3
$12.6M Buy
51,783
+1,955
+4% +$457K 1.7% 42
2024
Q2
$10.9M Buy
49,828
+3,683
+8% +$800K 1.7% 44
2024
Q1
$10.4M Buy
46,145
+5,407
+13% +$1.22M 1.66% 42
2023
Q4
$8.96M Buy
40,738
+6,260
+18% +$1.32M 1.76% 33
2023
Q3
$7.57M Sell
34,478
-256
-0.7% -$57.9K 1.94% 15
2023
Q2
$7.81M Buy
34,734
+3,104
+10% +$621K 1.91% 16
2023
Q1
$6.05M Buy
31,630
+1,472
+5% +$285K 1.72% 38
2022
Q4
$5.57M Buy
+30,158
New +$5.3M 1.64% 45

Other funds holding STE

Running Oak Capital's STE Position: Q2 2026 in Review

Running Oak Capital reduced its Steris (STE) stake by 17% in Q2 2026, selling an estimated $2.14M and leaving 48,335 shares worth $10.2M. The position accounts for 1.74% of the portfolio, ranked #34.

Running Oak Capital first reported a position in STE in Q4 2022 and has held it in 15 quarters since. The position peaked at $16.5M in Q3 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Running Oak Capital held 48,335 shares of Steris worth $10.2M as of Q2 2026.
  • Running Oak Capital sold 9,985 Steris shares in Q2 2026, an estimated $2.14M.
  • Steris made up 1.74% of Running Oak Capital's portfolio in Q2 2026, its #34 holding.
  • Running Oak Capital first reported a position in Steris in Q4 2022 and has held it in 15 quarters since.
  • Running Oak Capital's Steris position peaked at $16.5M in Q3 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Running Oak Capital's 13F filing for Q2 2026, filed 30 Jul 2026.